Results 201 to 210 of about 89,791 (356)

Paraplegia after Cystectomy and Epidural Anesthesia [PDF]

, 2000
Edmundo Pereira de Souza Neto, Robert Andreo, C Kopp, Denise M. Long, Jean-Marie Maréchal, P Boulétreau   +5 more
openalex   +1 more source

Urine‐Stable Aptamer‐Conjugated Gold Nanorods for the Early Detection of High‐Grade Bladder Cancer Residual Disease

Advanced Healthcare Materials, Volume 14, Issue 10, April 15, 2025.
Aptamer (A) conjugated gold nanorods (B) for the recognition of bladder cancer cells expressing the integrin α5β1 (C) and the visualization of the targeted GNRs@Chit‐Apt‐Itg by photoacoustic imaging at the surface of the orthotopic bladder cancer in the preclinical model (D).
Chiara Venegoni, Silvia Tortorella, Alessandra Caliendo, Irene Locatelli, Alessia Di Coste, Erica Locatelli, Filippo Capancioni, Emanuela Bua, Simona Camorani, Andrea Salonia, Francesco Montorsi, Jithin Jose, Marco Moschini, Laura Cerchia, Mauro Comes Franchini, Massimo Alfano   +15 more
wiley   +1 more source

Evaluation of a model to predict recurrence after radical cystectomy in bilharzial bladder cancer patients

, 1989
M Rafla, AS Ibrahim, Alain‐Jacques Valleron, JY Mary   +3 more
openalex   +2 more sources

Urethra-sparing cystectomy and orthotopic urinary diversion in women with malignant pelvic tumors [PDF]

, 2001
Arnulf Stenzl, L. Jarolím, P. Coloby, Silvia Golia, Georg Bartsch, Marek Babjuk, Tadao Kakizoe, Chris Robertson   +7 more
openalex   +1 more source

Patient‐Derived Bladder Cancer Organoids as a Valuable Tool for Understanding Tumor Biology and Developing Personalized Treatment

Advanced Science, Volume 12, Issue 13, April 3, 2025.
We have established the first Asian‐based bladder cancer PDOs biobank, demonstrating their accuracy in mirroring parental tumors’ properties. Drug screening reveals diverse sensitivities to chemotherapies and targeted therapies, validated by PDO xenografts and patient outcomes. Genetic profiling identifies key genes associated with response to standard
Hongda Zhao, Na Lin, Vincy Wing Sze Ho, Kang Liu, Xuan Chen, Hongwei Wu, Peter Ka‐Fung Chiu, Linda Huang, Zahra Dantes, Ka‐Leung Wong, Ho‐Fai Chau, Ivan Ching‐Ho Ko, Chris Ho‐Ming Wong, David Ka‐Wai Leung, Steffi Kar‐Kei Yuen, Dinglan Wu, Xiaofan Ding, Chi Fai Ng, Jeremy Yuen‐Chun Teoh   +18 more
wiley   +1 more source

Radical cystectomy for bladder cancer in Sub-Saharan Africa: techniques, challenges, and survival outcomes: a comprehensive review. [PDF]

BMC Surg
Nhungo CJ, Nyongole OV, Mkony CA.
europepmc   +1 more source

MULTIDISCIPLINARY THERAPY FOR ADVANCED BLADDER CANCER PARTIAL CYSTECTOMY PATIENTS

, 1988
Masahiro Hara, Michihisa Saegusa, Junzo Ochi, Takahumi Akagi, T Obama, Jun Yoshimoto, Yosuke Matumura, Hiroyuki Ohmori   +7 more
openalex   +2 more sources

Total Cystectomy [PDF]

Proceedings of the Royal Society of Medicine, 1938
openaire   +2 more sources

Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer

BJUI Compass, Volume 6, Issue 4, April 2025.
Abstract Objectives To compare the outcomes between re‐induction Bacillus Calmette‐Guérin (BCG) and sequential intravesical gemcitabine‐docetaxel (Gem/Doce) therapy in patients with high‐grade (HG) non‐muscle invasive bladder cancer (NMIBC) following failure of initial induction BCG.
Kylie Yen‐Yi Lim, Tran Ngoc An Huynh, Gavin Wei, Jincy Kuriakose, Obaidullah Fazli, David Pook, Sarah Ransley, Janice Downie, Scott Donnellan, Weranja Ranasinghe   +9 more
wiley   +1 more source

Advocating female genital-sparing cystectomy as the standard of care for women with bladder cancer Re: "2025 Canadian Urological Association Guideline: Muscle-invasive bladder cancer" (Can Urol Assoc J 2025;19:E1-16). [PDF]

Can Urol Assoc J
Ismail A, Kotb A.
europepmc   +1 more source